Stockreport

Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq

BIOSTAR PHARMS INC  (BSPM) 
PDF XIANYANG, China, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutica [Read more]